Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.

Wang, Bing; Zhang, Yuzhu; Ye, Meina; Wu, Jingjing; Ma, Lina; Chen, Hongfeng

Wang, Bing; Zhang, Yuzhu; Ye, Meina; Wu, Jingjing; Ma, Lina; Chen, Hongfeng.

Affiliation

Wang B; Department of Breast, Longhua Hospital Affiliated with Shanghai University of TCM, Shanghai 200032, China.
Zhang Y; Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, China.
Ye M; Department of Breast, Longhua Hospital Affiliated with Shanghai University of TCM, Shanghai 200032, China.
Wu J; Department of Breast, Longhua Hospital Affiliated with Shanghai University of TCM, Shanghai 200032, China.
Ma L; Department of Breast, Longhua Hospital Affiliated with Shanghai University of TCM, Shanghai 200032, China.
Chen H; Department of Breast, Longhua Hospital Affiliated with Shanghai University of TCM, Shanghai 200032, China.

Curr Drug Metab ; 20(10): 804-814, 2019.

Article de En | MEDLINE | ID: mdl-31424364

Sujet(s)
Mots clés

DDP resistance; breast cancer; cisplatin; exosomes; in vitro; miR-423-5p.

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Cisplatine / Résistance aux médicaments antinéoplasiques / MicroARN / Exosomes / Antinéoplasiques Limites: Female / Humans Langue: En Journal: Curr Drug Metab Sujet du journal: METABOLISMO / QUIMICA Année: 2019 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google